COX and the control of the pulmonary circulation

Thrombosis Research

Volumn 110, Issue 5-6, 2003, Pages 335-338

  Sprague, Randy S ^a   Stephenson, Alan H ^a   Olearczyk, Jeffery J ^a   Lonigro, Andrew J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypoxic pulmonary vasoconstriction; Indomethacin; Meclofenamate; Prostacyclin; V Q matching

Indexed keywords

ARACHIDONIC ACID; INDOMETACIN; MECLOFENAMIC ACID; NITROGEN; OXYGEN; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; BLOOD FLOW; BLOOD GAS TENSION; CONFERENCE PAPER; CONTROLLED STUDY; DOG; HEART OUTPUT; HYPOTHESIS; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; LUNG ALVEOLUS; LUNG CIRCULATION; LUNG VENTILATION; MALE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RABBIT; TISSUE OXYGENATION;

EID: 0142227002     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.08.007     Document Type: Conference Paper

References (13)

1. von Euler U.S., Lilijestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol. Scand. 12:1946;301-319.
2. 2 supports blood flow to hypoxic alveoli in anesthetized dogs. J. Appl. Physiol.: Respir., Environ. Exercise Physiol. 56:1984;1246-1251.
3. Sprague R.S., Thiemermann C., Vane J.R. Endogenous EDRF opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in rabbits. Proc. Natl. Acad. Sci. 89:1992;8711-8715.
4. 2 on hypoxic pulmonary vasoconstriction. J. Appl. Physiol.: Respir., Environ. Exercise Physiol. 51:1981;871-874.
5. Alexander J.M., Nyby M.D., Jasberg K.A. Prostaglandin synthesis inhibition restores hypoxic pulmonary vasoconstriction. J. Appl. Physiol.: Respir., Environ. Exercise Physiol. 42:1977;903-908.
6. Leffler C.W., Passmore J.C. Contribution of prostaglandins to the regulation of pulmonary vascular resistance in adult cats and dogs. Prostaglandins Med. 3:1979;3360-3443.
7. Vaage J.L., Bjertnaes L., Hauge A. The pulmonary vasoconstrictor response to hypoxia: effects of inhibitors of prostaglandin biosynthesis. Acta Physiol. Scand. 95:1975;95-101.
8. Weir E.K., McMurtry I.F., Tucker A., Reeves J.T., Grover R.F. Prostaglandin synthesis inhibitors do not decrease hypoxic pulmonary vasoconstriction. J. Appl. Physiol.: Respir., Environ. Exercise Physiol. 41:1976;714-718.
9. Hales C.A., Rouse E., Buchwald I.A., Kazemi H. Role of prostaglandins in aveolar hypoxic vasoconstriction. Respir. Physiol. 29:1977;151-162.
10. Gryglewski R.J., Korbut R., Ocetkiewicz A. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation. Nature (Lond.). 273:1978;765-767.
11. 2. J. Appl. Physiol.: Respir., Environ. Exercise Physiol. 45:1978;408-413.
12. Stephenson A.H., Sprague R.S., Losapio J.L., Lonigro A.J. Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit. Am. J. Physiol. 284:2003;H2153-H2161.
13. Birks E.K., Bousamra M., Presberg K., Marsh J.A., Effros R.M., Jacobs E.R. Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue. Am. J. Physiol. 272:1997;L823-L829.